Stockguru.com: Stocks to Watch for December 5, 2008 - VBDG, TBIO, VION, CGYV, AOGN, and PPRW

Dec 05, 2008 (M2 PRESSWIRE via COMTEX) -- VION | Quote | Chart | News | PowerRating -- Our Stocks to Watch today include : Vertical Branding, Inc. (OTCBB: VBDG), Transgenomic Inc. (OTCBB: TBIO), Vion Pharmaceuticals Inc. (OTCBB: VION), China Energy Recovery, Inc. (OTCBB: CGYV), Avalon Oil and Gas, Inc. (OTCBB: AOGN), and Premier Power Renewable Energy, Inc. (OTCBB: PPRW)

Visit: http://www.stockguru.com to register for our daily Stocks to Watch and Trade Alerts.

Vertical Branding, Inc. (OTCBB: VBDG | Quote | Chart | News | PowerRating) Shares stayed steady at $0.11

Vertical Branding, Inc., through its subsidiaries, engages in the marketing and sale of household, beauty, and personal care products in the United States. The company offers its products to retailers, such as mass merchants, department stores, and drug stores, as well as to home shopping channels, catalogue proprietors, and international distributors. It also engages in the development, rental, and/or sale of commercial real estate properties in Granby, Connecticut. The company was founded in 2004 and is headquartered in Encino, California.

VBDG News Yesterday, Vertical Branding announced that it has received nearly $1 million in replenishment retail orders for its MyPlace(tm) product based on the strength of Thanksgiving weekend sales at one of the world's largest specialty retailers. MyPlace(tm) is a folding laptop computer workstation with conveniently folding legs and a tilting surface where a laptop user can secure the laptop while sitting in bed, in a comfortable chair or anywhere else that lacks a desk surface. MyPlace(tm) features a slim, lightweight and compact design, four pre-set positions for optimal comfort, fold-out legs for stability, a tilted mouse pad and a built-in LED light wand. It can be set up or folded up for storage in seconds. ''The velocity of MyPlace sales this past holiday weekend, numbering in the tens of thousands of units with one retail account in particular, is encouraging,'' said Nancy Duitch, Vertical Branding CEO. ''Our product development and marketing strategies focused on practical, high-quality, and affordable household items appears to be serving us well as we progress into the holiday shopping season.''

Transgenomic Inc. (OTCBB: TBIO | Quote | Chart | News | PowerRating) Shares traded up 6.67% at $0.32

Transgenomic, Inc. provides products for the synthesis, purification, and analysis of nucleic acids used in the life sciences industry for research primarily on molecular genetics and diagnostics. It also provides genetic variation analytical services to the medical research, clinical, and pharmaceutical markets. Transgenomic offers bioinstruments, bioconsumables, and discovery services. The company?s principal product includes WAVE System, a bioinstrument, which has broad applicability to genetic variation detection in molecular genetic research and molecular diagnostics. It also offers bioconsumable products, which include SURVEYOR Nuclease and a range of high pressure liquid chromatography separation columns; and consumable products that can be used on multiple independent platforms. In addition, Transgenomic provides discovery services, such as genomic biomarker analysis services to pharmaceutical and biopharmaceutical companies to support preclinical and clinical development of targeted therapeutics; and molecular-based testing services for hematology, oncology, and certain inherited diseases. The company?s customers include academic and medical institutions, as well as pharmaceutical, biotech, and commercial companies. Transgenomic sells its products through direct sales and support staff in the United States, the United Kingdom, and in western Europe; and through dealers and distributors in the rest of the world. The company was founded in 1997 and is based in Omaha, Nebraska.

TBIO News Yesterday, Transgenomic announced that the Clayton Foundation for Research of Houston, Texas through its technology transfer entity, the Research Development Foundation, has granted the Company an exclusive license to patents covering a method for mitochondrial DNA (mtDNA) damage detection. The patents form the basis for the development of diagnostic tests in cardiovascular disease, diabetes, degenerative diseases of aging, cancer, and other diseases, by measuring increased oxidative damage within mitochondria.

Vion Pharmaceuticals Inc. (OTCBB: VION | Quote | Chart | News | PowerRating) Shares traded up 76.67% at $0.53

Vion Pharmaceuticals, Inc., a development-stage pharmaceutical company, together with its subsidiaries, develops and commercializes therapeutics for the treatment of cancer. The company?s products in clinical development include Cloretazine, an alkylating agent that is in new phase 3 trial development stage for the treatment of relapsed acute myelogenous leukemia (AML); in phase 2 trial for the treatment of de novo poor-risk AML in previously untreated elderly patients; in phase I investigator-sponsored trial in combination with stem cell transplantation for patients with poor-prognosis hematologic malignancies; and in phase I/II investigator-sponsored trial in combination with temozolomide for the treatment of adult brain tumors. It also conducts a phase 1 clinical trial of an oral formulation of Triapine that is used to prevent the replication of tumor cells. In addition, the company?s products in preclinical development include VNP40541, a cytotoxic compound for hypoxic cells found in cancerous tumors; and TAPET, a drug delivery technology for the treatment of cancer. Further, its other products include MELASYN, a water-soluble, synthetic version of melanin that is used as an ingredient for formulation of skin care products and cosmetics; and elvucitabine, which is in phase II clinical trial for the treatment of human immunodeficiency virus and hepatitis B. Vion Pharmaceuticals has licensing agreements with Yale University related to Cloretazine, Triapine, MELASYN, and elvucitabine products; and with Austrian Inventors and Austria Wirtschaftsservice Gesellschaft m.b.H. for the development of hydrazones. It also has an agreement with the Institut Paoli-Calmettes to conduct a multi-center Phase I/II clinical trial of laromustine (Cloretazine (VNP40101M)). The company was founded in 1992. It was formerly known as OncoRx, Inc. and changed its name to Vion Pharmaceuticals, Inc. in 1996. Vion Pharmaceuticals is based in New Haven, Connecticut.

VION News Yesterday, Vion Pharmaceuticals made several announcements related to events in connection with the 50th American Society of Hematology Annual Meeting at the Moscone Center in San Francisco from December 6-9, 2008. Vion will introduce Onrigin(TM) as the new trade name for laromustine at the Meeting, replacing Cloretazine (VNP40101M).The Company is co-sponsoring a seminar at the Meeting, in conjunction with MGI Pharmaceuticals and the Geriatric Oncology Consortium, entitled "Treating AML/MDS in the Elderly: New Solutions for a Long-Standing Problem." The seminar will take place in Rooms 3009, 3011, 3022 and 3024 on Friday, December 5 from 12:30 p.m. to 4:30 p.m. at the Moscone Center West.

China Energy Recovery, Inc. (OTCBB: CGYV | Quote | Chart | News | PowerRating) Shares traded down 5.88% at $1.60

China Energy Recovery, Inc. is an international leader in energy recovery systems, with a primary focus on the Chinese market. CER's technology captures industrial waste energy to produce low-cost electrical power, enabling industrial manufacturers to reduce their energy costs, shrink their emissions footprint, and generate sellable emissions credits. CER has deployed its systems throughout China and in such international markets as Egypt, Turkey, Korea, Vietnam and Malaysia. CER focuses on numerous industries in which a rapid payback on invested capital is achieved by its customers, including: chemical, petro-chemicals, refining (including Ethanol refining), coke processing, and the manufacture of paper, cement and steel. CER continues to invest in R&D and plans to build China's first state-of-the-art energy recovery system research and fabrication facility to allow it to meet the increased demand for its products and services.

CGYV News Yesterday, China Energy Recovery announced that the company has established a new subsidiary, CER Energy Recovery (Shanghai) Co., Ltd. ("CER Shanghai"), as one of its strategic initiatives to expand its operations to meet the market demands from both China and abroad. CER Shanghai will serve as a new operating subsidiary and the R&D center of CER in China and is strategically established in Shanghai Zhangjiang Hi-tech Park ("Zhangjiang" or "Park"). "It's our great honor to be invited as one of the first clean technology companies to establish operations in Zhangjiang," stated CER Chairman of the Board and CEO, Mr. Qinghuan Wu. "With CER's primary focus at this time on increasing production capacity and developing technology to achieve more efficiency in capturing waste energy, we feel our business will proudly represent China's energy efficiency sector to the world. Our expansion into new industries will also allow us to adapt and improve our technology to better satisfy the needs of the broadening base of our customers."

Avalon Oil and Gas, Inc. (OTCBB: AOGN | Quote | Chart | News | PowerRating) Shares traded up 15% at $0.023

Avalon Oil & Gas, Inc. engages in the acquisition of producing oil and gas properties in the United States. The company, through its subsidiaries, also holds licenses for the mitigation of paraffin wax deposition from crude oil using ultrasonic waves; for a borehole casing technology; and for a leak detection and location technology. Avalon Oil & Gas, Inc. has a strategic alliance with UTEK Corporation to develop a portfolio of new technologies for the oil and gas industry. The company is based in Minneapolis, Minnesota.

AOGN News Yesterday, Avalon Oil & Gas reported its financial results for the six months ending September 30, 2008. In the Form 10-QSB the Company filed with the Securities and Exchange Commission (SEC), Avalon reported revenues for the six month period of $247,865, a 147% increase over the comparable period in 2007. Avalon's revenues for the three month period ending September 30, 2008, were $134,725, an increase of 134% from the prior year's three month period ending September 30, 2007. Shareholder's equity increased to $3,056,446, or $0.06 per share for the period ending September 30, 2008, an increase of 31% over the period ending September 30, 2007.

Premier Power Renewable Energy, Inc. (OTCBB: PPRW | Quote | Chart | News | PowerRating) Shares traded up 22.95% at $3.75

Premier Power Renewable Energy, Inc. offers solar electric power systems installation services. The company was founded in 1986 and is based in El Dorado Hills, California.

PPRW News Yesterday, Premier Power Renewable Energy announced that former California state senator and green energy advocate Kevin Murray has been elected to Premier Power's board of directors. As a California state senator, Senator Murray was a strong advocate for green energy initiatives and played a leadership role in the authoring and passing of key solar legislation. Mr. Murray authored SB1 the landmark "Million Solar Roofs" bill providing over Three Billion Dollars to expand the use of solar energy in California under which California and other solar initiatives are being based. Senator Murray worked closely with those in California state government from the governor's office and his colleagues in the legislative branch to create the solar initiative that has made California a national and international leader in solar energy and provides a model "solar initiative" that is the blueprint for other states and countries around the world.

About StockGuru.com:

StockGuru.com is an investment information web site for smallcap and over-the-counter bulletin board stocks. StockGuru features daily email alerts to members, company profiles, audio interviews of CEO's or other key executives, and company news. Company and financial reports are authored by business analysts. To join our email alert list, please visit: http://www.stockguru.com/index.php?option=com_content&view=article&id=31&Itemid=5

About ShareholderVision.com:

Occasionally companies mentioned are also featured at ShareholderVision.com. This innovative web site featuring company videos of corporate executives and key personnel. All videos are shot in high-definition format and are edited for content purposes.

To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031, or you email us at email: john@stockguru.com and we will gladly send you more information on featuring your company with StockGuru.com

Stockguru.com ("SG") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.

CONTACT: John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index